home / stock / avcnf / avcnf articles

AVCNF Articles, Avicanna Inc - From 04/02/24

Stock Information
Company Name: Avicanna Inc
Stock Symbol: AVCNF
Market: OTC
Website: avicanna.com
Menu
AVCNF AVCNF Quote AVCNF Short AVCNF News AVCNF Articles AVCNF Message Board
Get AVCNF Alerts

News, Short Squeeze, Breakout and More Instantly...
Avicanna Reports Full Year 2023 Audited Financial Results | Benzinga

$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an increase of 500% from 2022 TORONTO, ...
Avicanna To Hold Full Year 2023 Earnings Conference Call | Benzinga

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharmaceutical com...

Avicanna Hosts Symposium on Cannabinoid-based Medicine | Benzinga

TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) a biopharmaceutical co...

Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global | Benzinga

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (OTC: CLVRW), a prominent global medical cannabis company announced a strategic partnership wi...
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal | Benzinga

Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced on Monday that it had reached an exclusive supply agreement for its two proprietary top...

Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company | Benzinga

Exclusive supply agreement for two of Avicanna's proprietary topical products in the European region Right of first refusal agreement for the...

CBD-Focused Avicanna Announces Funding Boost For Research And Development | Benzinga

Cannabinoid-based biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Monday that it has closed a non-broker...
Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform | Benzinga

Avicanna Inc. (OTCQX: AVCNF) a biopharmaceutical company specializing in proprietary cannabinoid-based products, announced Q3 2023 result...

Avicanna Announces Appointment of Paul Fornazzari to Board of Directors | Benzinga

TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) a biopharmaceutical co...

Avicanna To Hold Third Quarter 2023 Earnings Conference Call | Benzinga

TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharmaceutical comp...
Previous 10 Next 10